Custom service

Stapled Peptide Design

Design hydrocarbon-stapled peptides for helical binding and cell uptake

Turnaround: 5–9 weeksTypical scale: 0.1 mg – 10 g per sequenceChemistry options: i,i+4 and i,i+7 staple geometry; oleic-acid staple placement modeling; permeability vs binding trade-off design

Stapled Peptide Design supports programmes that design hydrocarbon-stapled peptides for helical binding and cell uptake. In a typical engagement we plan the i,i+4 and i,i+7 staple geometry route first, confirm compatibility with oleic-acid staple placement modeling, and release stapled peptide designs with synthesis routes on a 5–9 weeks schedule.

Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep i,i+4 and i,i+7 staple geometry as the primary option and hold oleic-acid staple placement modeling in reserve, so that scale-up never depends on an unproven step.

P53-MDM2-class helical PPI targets

Improving cell uptake of helical binders

Targets where helicity is not the binding mode

Sequences where a recombinant expression route is objectively cheaper and faster

Release specification is fixed at quotation: standard >95% by HPLC, >98% for assay-critical material. Long chains (>60 residues) are additionally confirmed by MS/MS sequence coverage, and truncated-deletion species are quantified, not just summarized.

Service Highlights

  • I,i+4 and i,i+7 staple geometry as the default route, with oleic-acid staple placement modeling held as a proven fallback
  • Permeability vs binding trade-off design worked into the design where the application requires it
  • Sequence difficulty analysis (aggregation risk, motif hazards) is done before synthesis, and the route is chosen around it
  • Analytical confirmation of every intermediate before the final release
  • Microwave-assisted coupling and double-coupling are applied automatically where the sequence demands them
  • Stapled peptide designs with synthesis routes delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Sequence analysis

    Stapled Peptide Design is analyzed for aggregation risk, motif hazards and puri?cation difficulty before a route is quoted.

  2. Route selection

    Fmoc solid-phase, fragment ligation or hybrid solution-phase is selected and documented.

  3. Assembly

    The chain is built with i,i+4 and i,i+7 staple geometry applied where the sequence demands it, with double-coupling at hazard sites.

  4. Cleavage & crude QC

    Crude material is characterized so purification targets are set on data, not hope.

  5. Purification

    RP-HPLC (and ion-exchange where needed) delivers the agreed purity; fractions are pooled on MS confirmation.

  6. Release

    Stapled peptide designs with synthesis routes is documented with the full analytical package and released.

Specifications & timeline

Turnaround
5–9 weeks
Typical scale
0.1 mg – 10 g per sequence
Chemistry options
i,i+4 and i,i+7 staple geometry; oleic-acid staple placement modeling; permeability vs binding trade-off design
Deliverable
Stapled peptide designs with synthesis routes
QC package
HPLC purity, ESI/MALDI MS, MS/MS confirmation for long chains
Shipping
Ambient with desiccant; blue ice for modified or sensitive peptides

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.